Complications in Treatment of 31-A Fractures with Trochanteric Gamma Nail (TGN) Versus Gamma3 Nail (G3N) - A Review of 217 Cases
R. Schupfner1, *, #, L.T. Käsmann2, #, W. Wagner1, A.P. Schulz2
1 Department of Traumatology, Orthopaedics & Reconstructive Surgery, Clinic Bayreuth, Germany
2 Department of Orthopaedics & Traumatology, University of Lübeck, Germany
The aim of this study was to clinically evaluate two generations of intramedullary gamma-nail used in the treatment of 31-A femur fractures.
Materials and Methods:
In two consecutive series, 117 trochanteric gamma nails (TGN) and 100 Gamma3 nails (G3N) were implanted for the treatment of inter- and subtrochanteric fractures between 2009 and 2011. Clinical and radiological follow-up examinations were assessed. An analysis of surgical time, hemoglobin drop and complications were performed.
Average surgical time, fluoroscopy time, haemoglobin drop and length-of-stay (LOS) were similar in both groups. No significant differences were found in surgery-related complications like wound hematomas (p=0,59), abscesses (p=0,38), wound infections (p=0,69) and Cut-outs (p=0,69) between the two groups. The cumulative surgery-related complication rate was higher in the TGN group compared to the G3N group (13,68% vs. 8%) but this did not reach statistical significance (p=0,2).
Our findings suggest that both TGN and G3N allow adequate treatment of trochanteric fractures with an acceptable complication rate.
This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0)
(https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the
work is properly cited.
* Address correspondence to this author at the Department of Traumatology, Orthopaedics & Reconstructive Surgery, Clinic Bayreuth, Germany; Tel: +49 921-4005311; E-mail: email@example.com
#These authors contributed equally to the manuscript.